Market Coverage: Wednesday October 14 Yahoo Finance

Get the latest up-to-the-minute continuous stock market coverage and big interviews in the world of finance every Monday–Friday from 9 am to 5pm (ET).
#YahooFinance #Stocks #coronaviruscovid19
The lineup:
9am - 11am: The First Trade
11am - 1pm: On The Move
1pm - 3pm: The Ticker
3pm - 5pm: The Final Round
#Stockmarket #coronavirus #YahooFinance
#YahooFinance #investing #stockmarket

Stock futures traded flat to slightly lower Wednesday morning, as a host of major banks released their quarterly results.

Goldman Sachs (GS) on Wednesday reported third-quarter results that well exceeded consensus estimates, as investment banking and fixed income trading revenue each grew over last year and topped expectations. The trading boost Goldman Sachs and other banks including JPMorgan Chase and Citigroup but it did not extend to Bank of America (BAC), which posted lighter-than-expected trading revenue from stocks and bonds, and a miss on overall revenue compared to estimates. Bank of America also built its credit reserves during the quarter, adding more padding in case of potential customer loan defaults amid the pandemic.

Meanwhile, lackluster prospects for more stimulus and concerns over the timeline for developing a COVID-19 vaccine and treatment weighed on investors. Each of the S&P 500, Dow and Nasdaq declined for the first time in five sessions as of Tuesday’s close.

An impasse among U.S. lawmakers in Washington has kept hopes running low that more virus relief aid will come to fruition before the November election. Senate Majority Leader Mitch McConnell said Tuesday he will have the Senate take up relief legislation after the chamber’s return on Monday, with his narrower proposal set to include funds chiefly targeted to the Paycheck Protection Program. House Speaker Nancy Pelosi, however, has rejected slimmed-down stimulus proposals and deemed them inadequate, and even President Donald Trump said on Tuesday on Twitter to “Go big or go home!!!” for more stimulus.

Meanwhile, a pair of front-runners in the race to develop a COVID-19 vaccine and treatment announced that their respective trials were put on pause over safety concerns. Eli Lilly (LLY) said Tuesday afternoon that enrollment for its COVID-19 treatment would be temporarily halted, less then a day after Johnson & Johnson (JNJ) said clinical trials for its COVID-19 vaccine candidate were paused due to an unexplained illness in a participant. Shares of Eli Lilly and Johnson & Johnson were little changed overnight after dropping during Tuesday’s session..

For more on this article please visit:
https://finance.yahoo.com/news/stock-market-news-live-october-14-2020-221639106.html

Видео Market Coverage: Wednesday October 14 Yahoo Finance канала Yahoo Finance